Login / Signup

Randomized phase II study of capecitabine plus cisplatin with or without sorafenib in patients with metastatic gastric cancer (STARGATE).

Min-Hee RyuKyung Hee LeeLin ShenKun-Huei YehChanghoon YooYoung Seon HongYoung Iee ParkSung Hyun YangDong Bok ShinDae Young ZangWon Ki KangIk-Joo ChungYeul Hong KimBaek-Yeol RyooByung-Ho NamYoung Soo ParkYoon-Koo Kang
Published in: Cancer medicine (2022)
The addition of sorafenib to XP chemotherapy was safe but not more effective than XP alone for first-line treatment of metastatic gastric cancer.
Keyphrases